Related Experiment Videos
Hypericin-based fluorescence diagnosis of bladder carcinoma
Marie-Ange D'Hallewin1, A R Kamuhabwa, T Roskams
1Department of Urology, UZ Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. marie-ange.dhallewin@uz.kuleuven.ac.be
BJU International
|April 23, 2002
Summary
Hypericin instillation offers a highly sensitive and specific method for fluorescently detecting bladder cancer, including carcinoma in situ. This approach shows promise for improved diagnostic accuracy in urologic oncology.
Area of Science:
- Urologic Oncology
- Medical Imaging
- Photodynamic Diagnosis
Background:
- Bladder cancer diagnosis relies on sensitive and specific methods.
- Current diagnostic techniques may have limitations in detecting all forms of bladder cancer, such as carcinoma in situ.
Purpose of the Study:
- To evaluate the efficacy of hypericin instillation for fluorescent detection of papillary bladder cancer and carcinoma in situ.
- To assess the sensitivity and specificity of hypericin-induced fluorescence for bladder cancer detection.
Main Methods:
- Eighty-seven patients with suspected bladder cancer received intravesical hypericin instillation.
- Fluorescence microscopy was used to examine biopsies after blue light excitation.
- The optimal timing after Bacillus Calmette-Guerin (BCG) instillations was investigated.
Main Results:
- Hypericin instillation demonstrated high sensitivity (94%) and specificity (95%) for detecting carcinoma in situ.
- All papillary lesions exhibited red fluorescence, with selective localization of hypericin in the epithelium.
- No adverse side-effects or photobleaching were reported.
Conclusions:
- Hypericin-induced fluorescence is a sensitive and specific tool for diagnosing bladder cancer.
- A 4-month interval post-BCG treatment minimizes false-positive results.
- This method enhances the fluorescent detection of bladder tumors.